Segui
Taiyeb Khumri
Taiyeb Khumri
Assistant Professor of Medicine, University of Missouri at Kansas City
Nessuna email verificata
Titolo
Citata da
Citata da
Anno
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
ME Nassif, SL Windsor, BA Borlaug, DW Kitzman, SJ Shah, F Tang, ...
Nature medicine 27 (11), 1954-1960, 2021
5272021
Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies
LL Kusnetzky, A Khalid, TM Khumri, TG Moe, PG Jones, ML Main
Journal of the American College of Cardiology 51 (17), 1704-1706, 2008
1772008
Clinical predictors of left atrial thrombus and spontaneous echocardiographic contrast in patients with atrial fibrillation
VJ Rader, TM Khumri, M Idupulapati, CN Stoner, A Magalski, ML Main
Journal of the American Society of Echocardiography 20 (10), 1181-1185, 2007
682007
Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation
TM Khumri, M Idupulapati, VJ Rader, S Nayyar, CN Stoner, ML Main
The American journal of cardiology 99 (12), 1733-1736, 2007
492007
Usefulness of left ventricular diastolic dysfunction as a predictor of one-year rehospitalization in survivors of acute myocardial infarction
TM Khumri, KJ Reid, M Kosiborod, JA Spertus, ML Main
The American journal of cardiology 103 (1), 17-21, 2009
432009
Contrast administration reduces interobserver variability in determination of left ventricular ejection fraction in patients with left ventricular dysfunction and good baseline …
S Nayyar, A Magalski, TM Khumri, M Idupulapati, CN Stoner, ...
The American journal of cardiology 98 (8), 1110-1114, 2006
422006
Usefulness of myocardial contrast echocardiography in predicting late mortality in patients with anterior wall acute myocardial infarction
TM Khumri, S Nayyar, M Idupulapati, A Magalski, CN Stoner, ...
The American journal of cardiology 98 (9), 1150-1155, 2006
392006
Echocardiographic dyssynchrony and health status outcomes from cardiac resynchronization therapy: insights from the PROSPECT trial
PS Chan, T Khumri, ES Chung, S Ghio, KJ Reid, B Gerritse, ...
JACC: Cardiovascular Imaging 3 (5), 451-460, 2010
362010
Mortality rates and clinical predictors of reduced survival after cardioverter defibrillator implantation
JB Thibodeau, J Pillarisetti, TM Khumri, PG Jones, ML Main
The American journal of cardiology 101 (6), 861-864, 2008
272008
Effects of GLP-1 receptor agonists and SGLT-2 inhibitors in heart transplant patients with type 2 diabetes: Initial report from a cardiometabolic center of excellence
Y Sammour, M Nassif, M Magwire, M Thomas, T Fendler, T Khumri, ...
The Journal of Heart and Lung Transplantation 40 (6), 426-429, 2021
262021
Dapagliflozin improves heart failure symptoms and physical limitations across the full range of ejection fraction: pooled patient-level analysis from DEFINE-HF and PRESERVED-HF …
ME Nassif, SL Windsor, K Gosch, BA Borlaug, M Husain, SE Inzucchi, ...
Circulation: Heart Failure 16 (7), e009837, 2023
242023
Transesophageal echocardiographic diagnosis of left atrial appendage occluder device infection
TM Khumri, JB Thibodeau, ML Main
European Journal of Echocardiography 9 (4), 565-566, 2008
232008
PCSK9 inhibitors in heart transplant patients: safety, efficacy, and angiographic correlates
Y Sammour, C Dezorzi, BA Austin, AM Borkon, MP Everley, TJ Fendler, ...
Journal of Cardiac Failure 27 (7), 812-815, 2021
182021
Influence of donor transmitted and rapidly progressive coronary vascular disease on long-term outcomes after heart transplantation: a contemporary intravascular ultrasound analysis
BW Sperry, R Qarajeh, MA Omer, H Brandt, D Safley, AM Borkon, ...
Journal of Cardiac Failure 27 (4), 464-472, 2021
182021
Single‐center utilization of donor‐derived cell‐free DNA testing in the management of heart transplant patients
KT Gondi, A Kao, J Linard, BA Austin, MP Everley, TJ Fendler, T Khumri, ...
Clinical Transplantation 35 (5), e14258, 2021
152021
Clinical factors associated with left ventricular ejection fraction disparity in patients with left ventricular dysfunction undergoing multimodality imaging
A Khalid, SK Bhatti, M Al-Amoodi, JA House, TM Khumri, JH O’Keefe, ...
Missouri Medicine 109 (6), 489, 2012
122012
Apical pseudoaneurysm following continuous flow left ventricular assist device placement
AR Moser, D Hockman, A Magalski, ML Main, TM Khumri, BA Austin
Circulation: Heart Failure 5 (3), e53-e54, 2012
122012
Donor‐derived cell‐free DNA in a heart transplant patient with COVID‐19
BW Sperry, TM Khumri, AC Kao
Clinical transplantation 34 (11), 2020
112020
Effect of dapagliflozin on 6-minute walk distance in heart failure with preserved ejection fraction: PRESERVED-HF
GD Lewis, K Gosch, LP Cohen, ME Nassif, SL Windsor, BA Borlaug, ...
Circulation: Heart Failure 16 (11), e010633, 2023
102023
Characterization and timing of gastrointestinal bleeding in continuous flow left ventricular assist device recipients
D Kapuria, T Khumri, S Shamim, P Surana, S Khan, N Al-Khalisi, ...
Heliyon 6 (9), 2020
102020
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20